Cambridge, MA — July 14, 2025 — Alden Scientific, the leader in AI based multi-omic innovation and precision health technologies, announced the acquisition of Oncimmune Germany GmbH, a pioneering immunodiagnostics and biomarker company known for its leading antibody and autoantibody biomarker discovery platform, ImmunoINSIGHTS™. The acquisition provides Alden Scientific unique access to the world’s largest antigen library covering 9000+ human antigens and multi-species variants.